Budget impact analysis resulting from the use of dabigatran etexilate in preventing stroke in patients with non-valvular atrial fibrillation in Italy. (2012). Farmeconomia. Health Economics and Therapeutic Pathways, 13(3), 121-131. https://doi.org/10.7175/fe.v13i3.268